Toluene diisocyanate manufacturer Knowledge Methacholine chloride Acetyl-β-methylcholine chloride

Methacholine chloride Acetyl-β-methylcholine chloride

Methacholine chloride structural formula

Structural formula

Business number 01CD
Molecular formula C8H18ClNO2
Molecular weight 195.69
label

methacholine,

Acetyl-beta-methylcholine chloride,

Amechol,

O-Acetyl-β-methylcholine,

(2-Acetoxypropyl)trimethylammonium chloride,

Methacholine chloride,

(2-Hydroxypropyl)trimethylammonium chloride

Numbering system

CAS number:62-51-1

MDL number:MFCD00011817

EINECS number:200-537-2

RTECS number:BR5250000

BRN number:4162373

PubChem number:24277821

Physical property data

1. Properties: White needle-like crystals, easy to deliquesce. Slightly fishy smell.

2. Density (g/mL, 25/4℃): Undetermined

3. Relative vapor density (g/mL, air=1): Undetermined

4. Melting point (ºC): 172–173

5. Boiling point (ºC, normal pressure): Undetermined

6. Boiling point (ºC, 5.2kPa) : Undetermined

7. Refractive index: Undetermined

8. Flash point (ºC): Undetermined

9. Specific rotation (º): Undetermined

10. Autoignition point or ignition temperature (ºC): Undetermined

11. Vapor pressure (kPa, 25ºC): Undetermined

12 . Saturated vapor pressure (kPa, 60ºC): Undetermined

13. Heat of combustion (KJ/mol): Undetermined

14. Critical temperature (ºC): Undetermined

p>

15. Critical pressure (KPa): Undetermined

16. Log value of oil-water (octanol/water) partition coefficient: Undetermined

17. Explosion upper limit (%, V/V): Undetermined

18. Lower explosion limit (%, V/V): Undetermined

19. Solubility: Easily soluble in water, ethanol, Chloroform, insoluble in ether. It decomposes when exposed to alkali and slowly decomposes when exposed to water.

Toxicological data

Acute toxicity: Rat oral LD50: 750 mg/kg; Rat subcutaneous injection LD50: 75 mg/kg; Rat intravenous LD50: 20 mg/kg; Mouse oral LD50: 740 mg/kg; Mouse intraperitoneal LD50 : 160 mg/kg; mouse subcutaneous injection LD50: 15 mg/kg; guinea pig intravenous LDLo: 3750 mg/kg;

Ecological data

None yet

Molecular structure data

None yet

Compute chemical data

1. Reference values ​​for calculation of hydrophobic parameters���XlogP): None

2. Number of hydrogen bond donors: 0

3. Number of hydrogen bond acceptors: 3

4. Rotatable chemical bonds Number: 4

5. Number of tautomers: None

6. Topological molecule polar surface area 26.3

7. Number of heavy atoms: 12

8. Surface charge: 0

9. Complexity: 138

10. Number of isotope atoms: 0

11. Determine the atoms Number of stereocenters: 0

12. Uncertain number of stereocenters of atoms: 1

13. Determined number of stereocenters of chemical bonds: 0

14. Uncertain number of stereocenters of chemical bonds: 0

15. Number of covalent bond units: 2

Properties and stability

1. It is harmful if taken orally. When using, avoid inhaling the dust of this product and avoid contact with eyes and skin.

Storage method

1. Sealed or tightly sealed and stored dry at 40ºC. The solution should not be kept in refrigerated storage for more than two weeks.

Synthesis method

None yet

Purpose

1. Biochemical research.

2. It can stimulate M choline receptors, has strong selectivity for the cardiovascular system, and has a weak effect on gastrointestinal and bladder smooth muscles. It can also contract bronchial smooth muscles and increase bronchial secretion. It is stable and can be taken orally, but its absorption is small and irregular. It is inactivated slowly by cholinesterase in the body, so its effect is longer-lasting. It is mainly used for atrial tachycardia, but it is not the first choice and can be used again when other treatments are ineffective. It can also be used for peripheral vasospasm diseases, such as Raynaud’s disease and thromboangiitis obliterans. Oral administration, 200 to 500 mg each time, 2 to 3 times a day; subcutaneous injection, 10 to 25 mg each time.
Note:
(1) Symptoms of M choline receptor activation may occur in overdose (see bethanecholine).
(2) It is prohibited to be used for atrioventricular nodal and ventricular tachycardia, because it is not only ineffective, but can also cause atrial fibrillation.
(3) It is prohibited to be used in patients with bronchial asthma and hyperthyroidism.
(4) Intravenous injection is strictly prohibited.

This article is from the Internet, does not represent the position of Toluene diisocyanate reproduced please specify the source.https://www.chemicalchem.com/archives/23563

author:

Previous article
Next article
Contact Us

Contact us

+86 - 152 2121 6908

Online consultation: QQ交谈

E-mail: sales@newtopchem.com

Working hours: Monday to Friday, 9:00-17:30, closed on holidays
Follow wechat
Scan wechat and follow us

Scan wechat and follow us

Follow Weibo
Back to top
Home
E-mail
Products
Search